Verana Health announces $100 million financing led by GV
Verana Health , a technology company that is curating and analyzing clinical datasets, has announced it has acquired the technology assets and team behind Knoxville, TN-based PYA Analytics which specializes in large-scale data architecture solutions.
Verana Health also announced the close of a $100 million investment led by GV. New investors Bain Capital Ventures, Casdin Capital, and Define Ventures also participated in the round along with the company’s existing slate of investors. Renowned life sciences investor Brook Byers continues to serve as Chairman of Verana’s Board.
“Verana Health is building the team and technology to unlock deep clinical insights that support the development of new treatments while increasing our understanding of how these treatments can benefit patients more broadly. Under the leadership of its strong management team, Verana continues to redefine how we approach medical research.” – Dr. Krishna Yeshwant, General Partner at GV.
Verana’s platform aggregates regulatory-grade datasets through its partnership with two of the largest clinical databases in medicine, the American Academy of Ophthalmology (AAO) IRIS® Registry, and the American Academy of Neurology (AAN) Axon Registry®.
“Verana is assembling the most comprehensive datasets in medicine across multiple disease types with the goal of accelerating medical research for patients with ophthalmic and neurologic conditions. The financing and the addition of PYAA enable us to enrich these large clinical databases, creating a longitudinal view of the complete patient journey to inform research and patient care.” – Miki Kapoor, CEO of the Verana Health.
“PYA Analytics is a data science company that develops state-of-the-art products for data linking and analysis. We are thrilled to join Verana to enrich these extraordinary clinical databases and find answers to some of the most pressing challenges in medicine.” – Dr. Brian Worley, Co-founder and CEO of PYA Analytics.
The PYAA team will remain in Knoxville.